Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...

While traditional medications can provide relief, essential oils can also offer a natural alternative to address inflammation ...

Abeona Therapeutics Inc.'s promising gene therapy for RDEB, potential FDA approval, undervalued stock, and key risks. Click ...

Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

UTI symptoms can fade for a few days but then return. Here’s how to tell if your UTI is going away and how to use home ...

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

These stocks have climbed more than 80% and 200% over the past three years. But demand for their products and potential ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...

Purdue Pharma and its owner, the Sackler family, will pay $7.4 billion to resolve thousands of lawsuits. Those lawsuits alleged oxycontin pain medication led to the U.S. opioid addiction crisis. North ...

Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and physical quality of life vs. just guideline-recommended care, a randomized ...